Strengthening Investment Engagement in Rwanda Exon Genetic & Biotechnology and BEYLER GROUP have continued to engage with institutions in Rwanda as part of their interest in healthcare and investment opportunities in the country. On April 7, 2023, BEYLER GROUP Chairman of the Board Dr. Hulusi Söğütlü and Exon’s Rwanda representative
